X Peng,
J Treml,
Y Paterson.
(2007)
" Adjuvant properties of listeriolysin O protein in a DNA vaccination strategy.
"
Cancer Immunol Immunother
56.
797-806
PMID:
17102978
DOI:
10.1007/s00262-006-0240-9
|
Abstract and Keywords
K Rezvani,
A Yong,
S Mielke,
B Jafarpour,
B Savani,
RQ Le,
R Eniafe,
L Musse,
C Boss,
R Kurlander,
JA Barrett.
(2010)
" Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T-cells in myeloid malignancies.
"
Haematologica
96.
432-40
PMID:
21134985
DOI:
10.3324/haematol.2010.031674
|
Abstract and Keywords
OE Rahma,
E Ashtar,
M Czystowska,
ME Szajnik,
E Wieckowski,
S Bernstein,
VE Herrin,
MA Shams,
SM Steinberg,
M Merino,
W Gooding,
C Visus,
AB Deleo,
JK Wolf,
JG Bell,
JA Berzofsky,
TL Whiteside,
SN Khleif.
(2011)
" A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients.
"
Cancer Immunol Immunother
61.
373-84
PMID:
21927947
DOI:
10.1007/s00262-011-1100-9
|
Abstract and Keywords
VV Parekh,
L Wu,
D Olivares-Villagómez,
KT Wilson,
L Van Kaer.
(2013)
" Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells.
"
J Immunol
190.
1948-60
PMID:
23345328
DOI:
10.4049/jimmunol.1201718
|
Abstract and Keywords